Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127674621 | 12767462 | 1 | I | 2015 | 20160915 | 20160921 | 20160921 | EXP | US-ASTRAZENECA-2016SE99929 | ASTRAZENECA | 84.00 | YR | F | Y | 62.10000 | KG | 20160921 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127674621 | 12767462 | 1 | SS | ATENOLOL. | ATENOLOL | 1 | Oral | 0 | 25 | MG | TABLET | QD | |||||||
| 127674621 | 12767462 | 2 | PS | MOVANTIK | NALOXEGOL OXALATE | 1 | Oral | U | U | 204760 | 25 | MG | TABLET | QD | |||||
| 127674621 | 12767462 | 3 | SS | MOVANTIK | NALOXEGOL OXALATE | 1 | Oral | U | U | 204760 | 25 | MG | TABLET | QD | |||||
| 127674621 | 12767462 | 4 | SS | MOVANTIK | NALOXEGOL OXALATE | 1 | Oral | U | U | 204760 | 25 | MG | TABLET | QD | |||||
| 127674621 | 12767462 | 5 | SS | MOVANTIK | NALOXEGOL OXALATE | 1 | Oral | U | U | 204760 | 25 | MG | TABLET | QD | |||||
| 127674621 | 12767462 | 6 | SS | MOVANTIK | NALOXEGOL OXALATE | 1 | Oral | U | U | 204760 | 25 | MG | TABLET | QD | |||||
| 127674621 | 12767462 | 7 | C | EDARBI | AZILSARTAN KAMEDOXOMIL | 1 | Oral | 0 | 5 | MG | QD | ||||||||
| 127674621 | 12767462 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 127674621 | 12767462 | 9 | C | WARFARIN | WARFARIN | 1 | Oral | 2 MG ON MONDAY AND FRIDAY AND 1.5 MG THE OTHER DAYS | 0 | ||||||||||
| 127674621 | 12767462 | 10 | C | WARFARIN | WARFARIN | 1 | Oral | 2 MG ON MONDAY AND FRIDAY AND 1.5 MG THE OTHER DAYS | 0 | ||||||||||
| 127674621 | 12767462 | 11 | C | KLOR-CON | POTASSIUM CHLORIDE | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 127674621 | 12767462 | 12 | C | ECOTRIN | ASPIRIN | 1 | Oral | 0 | 81 | MG | QD | ||||||||
| 127674621 | 12767462 | 13 | C | LORAZEPAM. | LORAZEPAM | 1 | Oral | 0.5MG AS REQUIRED | 0 | .5 | MG | ||||||||
| 127674621 | 12767462 | 14 | C | KRILL OIL | DIETARY SUPPLEMENT | 1 | Oral | DAILY | 0 | ||||||||||
| 127674621 | 12767462 | 15 | C | OXYCODONE | OXYCODONE | 1 | Oral | 0 | 5 | MG | BID | ||||||||
| 127674621 | 12767462 | 16 | C | OXYCODONE | OXYCODONE | 1 | Oral | EVERY 4 TO 6 HOURS AS REQUIRED | 0 | ||||||||||
| 127674621 | 12767462 | 17 | C | VICODIN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | 0 | .05 | MG | BID | ||||||||
| 127674621 | 12767462 | 18 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | 5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127674621 | 12767462 | 1 | Cardiovascular disorder |
| 127674621 | 12767462 | 2 | Constipation |
| 127674621 | 12767462 | 3 | Constipation |
| 127674621 | 12767462 | 4 | Constipation |
| 127674621 | 12767462 | 5 | Constipation |
| 127674621 | 12767462 | 6 | Constipation |
| 127674621 | 12767462 | 7 | Hypertension |
| 127674621 | 12767462 | 8 | Fluid retention |
| 127674621 | 12767462 | 9 | Atrial fibrillation |
| 127674621 | 12767462 | 10 | Anticoagulant therapy |
| 127674621 | 12767462 | 11 | Diuretic therapy |
| 127674621 | 12767462 | 12 | Cardiac disorder |
| 127674621 | 12767462 | 13 | Sleep disorder |
| 127674621 | 12767462 | 14 | Cardiovascular event prophylaxis |
| 127674621 | 12767462 | 15 | Pain |
| 127674621 | 12767462 | 16 | Pain |
| 127674621 | 12767462 | 17 | Pain |
| 127674621 | 12767462 | 18 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127674621 | 12767462 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127674621 | 12767462 | Activities of daily living impaired | |
| 127674621 | 12767462 | Atrial fibrillation | |
| 127674621 | 12767462 | Back pain | |
| 127674621 | 12767462 | Constipation | |
| 127674621 | 12767462 | Drug dose omission | |
| 127674621 | 12767462 | Groin pain | |
| 127674621 | 12767462 | Insomnia | |
| 127674621 | 12767462 | Pain in extremity | |
| 127674621 | 12767462 | Peripheral swelling | |
| 127674621 | 12767462 | Pulmonary oedema |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127674621 | 12767462 | 2 | 20160910 | 20160911 | 0 | |
| 127674621 | 12767462 | 3 | 20160912 | 0 | ||
| 127674621 | 12767462 | 4 | 20160913 | 0 | ||
| 127674621 | 12767462 | 5 | 20160914 | 0 | ||
| 127674621 | 12767462 | 6 | 20160915 | 0 | ||
| 127674621 | 12767462 | 7 | 201609 | 0 | ||
| 127674621 | 12767462 | 15 | 201608 | 0 | ||
| 127674621 | 12767462 | 17 | 201608 | 0 | ||
| 127674621 | 12767462 | 18 | 201609 | 0 |